Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > GREAT PRESS RELEASE, BUT ANOTHER DANGLING CARROT AND NO CASH

<< Previous

Bullboard Posts

Next >>

Comment by PeterGon Jun 28, 2023 12:42pm

113 Views

Post# 35518765

RE:GREAT PRESS RELEASE, BUT ANOTHER DANGLING CARROT AND NO CASH

As long as Howard and Chris are on top of this company, these dangling carrots will be our normal routine. Thanks again to Geraldine for the hard work on that Antiviral compound. European enthuisim meets Canadian lack of professionalism. Greetings from Germany.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments